BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2958962)

  • 1. Mycobacterium avium-complex infections in normal and immunodeficient mice.
    Collins FM; Stokes RW
    Tubercle; 1987 Jun; 68(2):127-36. PubMed ID: 2958962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and expression of protective T cells during Mycobacterium avium infections in mice.
    Appelberg R; Pedrosa J
    Clin Exp Immunol; 1992 Mar; 87(3):379-85. PubMed ID: 1544223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis.
    Flórido M; Gonçalves AS; Silva RA; Ehlers S; Cooper AM; Appelberg R
    Infect Immun; 1999 Jul; 67(7):3610-8. PubMed ID: 10377146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immune responses in Mycobacterium avium-infected mice.
    Hubbard RD; Flory CM; Collins FM
    Infect Immun; 1992 Jan; 60(1):150-3. PubMed ID: 1729179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.
    Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K
    Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of experimental model animals for disseminated Mycobacterium avium complex infections using immunodeficient mice and rats].
    Emori M; Saito H; Tomioka H; Setogawa T
    Kekkaku; 1994 Apr; 69(4):317-22. PubMed ID: 8189685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Commemorative lecture of receiving Imamura Memorial Prize. Characterization of immunosuppressive macrophages induced in mice infected with Mycobacterium intracellulare].
    Tomioka H
    Kekkaku; 1993 Dec; 68(12):767-75. PubMed ID: 8301920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenicities of Mycobacterium intracellulare and M. avium strains to the mice which were isolated from non-tuberculous mycobactriosis patients].
    Goto Y; Iwakiri A; Shinjo T
    Kansenshogaku Zasshi; 2002 Jun; 76(6):425-31. PubMed ID: 12136650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the virulence for mice of Mycobacterium avium and Mycobacterium intracellulare identified by DNA probe test.
    Tomioka H; Saito H; Sato K; Dawson DJ
    Microbiol Immunol; 1993; 37(4):259-64. PubMed ID: 8350768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium.
    Borges M; Rosa GT; Appelberg R
    Clin Exp Immunol; 2011 Jun; 164(3):407-16. PubMed ID: 21470210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge.
    Kelley CL; Collins FM
    Tuber Lung Dis; 1999; 79(6):367-70. PubMed ID: 10694981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.
    Kobayashi K; Yamazaki J; Kasama T; Katsura T; Kasahara K; Wolf SF; Shimamura T
    J Infect Dis; 1996 Sep; 174(3):564-73. PubMed ID: 8769615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104.
    Saunders BM; Dane A; Briscoe H; Britton WJ
    Immunol Cell Biol; 2002 Dec; 80(6):544-9. PubMed ID: 12406388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.
    Appelberg R; Sarmento AM
    Clin Exp Immunol; 1990 Jun; 80(3):324-31. PubMed ID: 2115416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive macrophages induced in Mycobacterium avium complex infection induced in mice].
    Tomioka H; Saito H
    Kekkaku; 1992 Jan; 67(1):47-54. PubMed ID: 1542208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.
    Stokes RW; Collins FM
    Clin Exp Immunol; 1990 Jul; 81(1):109-15. PubMed ID: 2116245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible BALB/c mice.
    Castro AP; Aguas AP; Silva MT
    Clin Exp Immunol; 1993 Jun; 92(3):466-72. PubMed ID: 8513578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.
    Florido M; Appelberg R; Orme IM; Cooper AM
    Immunology; 1997 Apr; 90(4):600-6. PubMed ID: 9176115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to infection with Mycobacterium avium is paradoxically correlated with increased synthesis of specific anti-bacterial antibodies.
    Ferreira P; Soares R; Arala-Chaves M
    Int Immunol; 1991 May; 3(5):445-52. PubMed ID: 1911533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.